Simplex Trading’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $14.4M | Sell |
392,803
-624,359
| -61% | -$29.6M | 0.01% | 542 |
|
|
2025
Q4 | $51.8M | Buy |
1,017,162
+421,560
| +71% | +$21.6M | 0.03% | 285 |
|
|
2025
Q3 | $33M | Buy |
595,602
+290,365
| +95% | +$17M | 0.02% | 465 |
|
|
2025
Q2 | $21.1M | Buy |
305,237
+66,227
| +28% | +$4.5M | 0.01% | 543 |
|
|
2025
Q1 | $16.6M | Buy |
+239,010
| New | +$19.7M | 0.01% | 609 |
|
|
2024
Q4 | – | Sell |
-12,717
| Closed | -$1.38M | – | 9289 |
|
|
2024
Q3 | $1.51M | Sell |
12,717
-104,650
| -89% | -$14M | ﹤0.01% | 2525 |
|
|
2024
Q2 | $16.8M | Sell |
117,367
-72,289
| -38% | -$9.58M | 0.01% | 706 |
|
|
2024
Q1 | $24.4M | Buy |
189,656
+116,505
| +159% | +$13.9M | 0.01% | 596 |
|
|
2023
Q4 | $7.57M | Buy |
73,151
+8,246
| +13% | +$815K | ﹤0.01% | 1275 |
|
|
2023
Q3 | $5.9M | Buy |
+64,905
| New | +$5.72M | ﹤0.01% | 1230 |
|
|
2022
Q4 | – | Sell |
-25,302
| Closed | -$1.48M | – | 10028 |
|
|
2022
Q3 | $1.26M | Buy |
25,302
+19,196
| +314% | +$1.03M | ﹤0.01% | 2386 |
|
|
2022
Q2 | $340K | Sell |
6,106
-31,782
| -84% | -$1.76M | ﹤0.01% | 3938 |
|
|
2022
Q1 | $2.1M | Sell |
37,888
-10,408
| -22% | -$534K | ﹤0.01% | 2055 |
|
|
2021
Q4 | $2.7M | Sell |
48,296
-21,338
| -31% | -$1.16M | ﹤0.01% | 1729 |
|
|
2021
Q3 | $2.94M | Sell |
69,634
-200
| -0.3% | -$9.67K | ﹤0.01% | 1691 |
|
|
2021
Q2 | $2.92M | Buy |
69,834
+41,690
| +148% | +$1.62M | ﹤0.01% | 1704 |
|
|
2021
Q1 | $948K | Buy |
+28,144
| New | +$1M | ﹤0.01% | 2464 |
|
|
2020
Q3 | – | Sell |
-15,306
| Closed | -$510K | – | 8260 |
|
|
2020
Q2 | $501K | Buy |
+15,306
| New | +$488K | ﹤0.01% | 2905 |
|
|
2020
Q1 | – | Sell |
-63,936
| Closed | -$1.9M | – | 8045 |
|
|
2019
Q4 | $1.85M | Buy |
63,936
+22,528
| +54% | +$624K | ﹤0.01% | 1548 |
|
|
2019
Q3 | $1.07M | Buy |
+41,408
| New | +$1.05M | ﹤0.01% | 1879 |
|
|
2018
Q4 | – | Sell |
-12,398
| Closed | -$276K | – | 7571 |
|
|
2018
Q3 | $292K | Sell |
12,398
-35,266
| -74% | -$861K | ﹤0.01% | 3213 |
|
|
2018
Q2 | $1.1M | Buy |
47,664
+26,958
| +130% | +$641K | ﹤0.01% | 1707 |
|
|
2018
Q1 | $509K | Buy |
20,706
+15,032
| +265% | +$395K | 0.02% | 704 |
|
|
2017
Q4 | $152K | Buy |
+5,674
| New | +$144K | 0.01% | 1493 |
|
|
2017
Q3 | – | Sell |
-5,246
| Closed | -$119K | – | 6393 |
|
|
2017
Q2 | $112K | Buy |
5,246
+4,814
| +1,114% | +$97.1K | ﹤0.01% | 1657 |
|
|
2017
Q1 | $7K | Sell |
432
-58,784
| -99% | -$1.02M | ﹤0.01% | 4311 |
|
|
2016
Q4 | $1.06M | Buy |
+59,216
| New | +$1.07M | 0.06% | 270 |
|
|
2016
Q1 | – | Sell |
-15,250
| Closed | -$409K | – | 6032 |
|
|
2015
Q4 | $442K | Buy |
+15,250
| New | +$422K | 0.03% | 478 |
|
|
2015
Q3 | – | Sell |
-3,838
| Closed | -$109K | – | 5980 |
|
|
2015
Q2 | $105K | Sell |
3,838
-10,874
| -74% | -$306K | 0.01% | 1181 |
|
|
2015
Q1 | $392K | Buy |
+14,712
| New | +$339K | 0.05% | 403 |
|
Other funds holding NVO
DAM
F
Simplex Trading's NVO Position: Q1 2026 in Review
Simplex Trading reduced its Novo Nordisk (NVO) stake by 61% in Q1 2026, selling an estimated $29.6M and leaving 392,803 shares worth $14.4M. The position accounts for 0.01% of the portfolio, ranked #542.
Simplex Trading first reported a position in NVO in Q1 2015 and has held it in 30 quarters since. The position peaked at $51.8M in Q4 2025. 1,272 funds tracked by Wall St. Rank hold NVO as of Q1 2026.
- Simplex Trading held 392,803 shares of Novo Nordisk worth $14.4M as of Q1 2026.
- Simplex Trading sold 624,359 Novo Nordisk shares in Q1 2026, an estimated $29.6M.
- Novo Nordisk made up 0.01% of Simplex Trading's portfolio in Q1 2026, its #542 holding.
- Simplex Trading first reported a position in Novo Nordisk in Q1 2015 and has held it in 30 quarters since.
- Simplex Trading's Novo Nordisk position peaked at $51.8M in Q4 2025.
- 1,272 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.
Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.